Brief: Ikena Oncology Posts Qtrly Loss Per Share $0.57
11/08/2022 14:58
Aug 11 (Reuters) - Ikena Oncology Inc IKNA.O :
* IKENA ONCOLOGY REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES A CORPORATE UPDATE
* IKENA ONCOLOGY INC QTRLY LOSS PER SHARE $0.57
Source text for Eikon: ID:nGNX3G4P7l
Further company coverage: IKNA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on ImageneBio
See all newsU.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals